Market Tracker

09/04 6:01pm ET

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

12.11
Delayed Data
As of Sep 04
 +0.18 / +1.51%
Today’s Change
8.34
Today|||52-Week Range
15.51
-15.43%
Year-to-Date

Today’s Trading

Previous close11.93
Today’s open11.88
Day’s range11.80 - 12.24
Volume560,957
Average volume (3 months)791,626
Market cap$504.5M
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+83.33%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+48.05%
P/E ratio9.4
Price/Sales10.47
Price/Book3.08

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...-0.21-1.48%
CARACara Therapeutics In...+0.08+0.42%
OTICOtonomy Inc+0.54+2.50%
SRNESorrento Therapeutic...+0.17+1.34%
Data as of 3:59pm ET, 09/04/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$50.2M
Annual profit (last year)$20.2M
Net profit margin40.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
CFO, Secretary, Treasurer &
Senior Vice President
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts